Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Hodgkin's Disease 2010 NCI 5R01CA131354-02 Inhibitors of Epstein-Barr Virus Nuclear Protein 1 Mediated Latent Infection KIEFF, ELLIOTT BRIGHAM AND WOMEN'S HOSPITAL MA $369,350
Hodgkin's Disease 2010 NCI 5R01CA073507-13 In Vivo Model of Epstein-Barr Virus Latency LONGNECKER, RICHARD NORTHWESTERN UNIVERSITY IL $499,500
Hodgkin's Disease 2010 NCI 5R01CA137894-02 EBV Antigen and Cell Cycle Regulation ROBERTSON, ERLE UNIVERSITY OF PENNSYLVANIA PA $294,131
Hodgkin's Disease 2010 NCI 5R37CA042245-25 Regulation of replication and latency EBV EBNAs HAYWARD, S JOHNS HOPKINS UNIVERSITY MD $330,635
Hodgkin's Disease 2010 NIAID 5R01AI018757-28 Host Immunity to EBV Infection in Vitro and in VIvo THORLEY-LAWSON, DAVID TUFTS UNIVERSITY BOSTON MA $408,375
Hodgkin's Disease 2010 NCI 5R37CA012055-38 Studies of Epstein-Barr Virus MILLER, I. YALE UNIVERSITY CT $461,604
Hodgkin's Disease 2010 NIAID 1R03AI085545-01 A FUNCTIONAL STUDY OF UBIQUITIN C-TERMINAL HYDROLASE L1 EXPRESSION IN B-LYMPHOMA SHACKELFORD, JULIA UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $74,000
Hodgkin's Disease 2010 NCI 5R01CA124311-04 Regulation of Epstein Barr virus reactivation through the co-activators, CBP/p300 FLEMINGTON, ERIK TULANE UNIVERSITY OF LOUISIANA LA $254,790
Hodgkin's Disease 2010 NCI 2R01CA068051-15 Pathogenesis of EBV Infection WANG, FREDERICK BRIGHAM AND WOMEN'S HOSPITAL MA $469,785
Hodgkin's Disease 2010 NCI 5R01CA098285-07 Towards a Mouse Model of Classical Hodgkin's Disease and PTLD RAJEWSKY, KLAUS IMMUNE DISEASE INSTITUTE, INC. MA $494,023
Hodgkin's Disease 2010 NCI 5R01CA117802-06 MYC-induced breach of B-cell anergy in AIDS-related NHLs REFAELI, YOSEF UNIVERSITY OF COLORADO DENVER CO $359,925
Hodgkin's Disease 2010 NIAID 5R01AI041769-13 Cellular Mechanisms of PTLD in Transplant Recipients MARTINEZ, OLIVIA STANFORD UNIVERSITY CA $411,227
Hodgkin's Disease 2010 NCI 5K23CA124465-03 Novel Biologic Therapies for Hodgkin's Lymphoma KASAMON, YVETTE JOHNS HOPKINS UNIVERSITY MD $140,940
Hodgkin's Disease 2010 NCI 5R01CA133063-03 Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD LONGNECKER, RICHARD NORTHWESTERN UNIVERSITY IL $274,204
Hodgkin's Disease 2010 NCI 5R01CA138268-02 Role of the cellular microRNA, miR-155, in EBV type III latency signaling FLEMINGTON, ERIK TULANE UNIVERSITY OF LOUISIANA LA $309,175
Hodgkin's Disease 2010 NCI 5K23CA113775-05 Proteosome Inhibition Therapy for Hematologic Malignancy HORTON, TERZAH BAYLOR COLLEGE OF MEDICINE TX $134,015
Hodgkin's Disease 2010 NCI 5R01CA058853-17 Regulation of EBV Infection in Epithelial Cells KENNEY, SHANNON UNIVERSITY OF WISCONSIN MADISON WI $293,684
Hodgkin's Disease 2010 NCI 5R01CA108609-07 Anti-viral DC/NK interactions MUNZ, CHRISTIAN UNIVERSITY OF ZURICH SWITZE $182,434
Hodgkin's Disease 2010 NCI 5R01CA131027-03 Chimeric T Cell for Therpay of Hodgkin Disease SAVOLDO, BARBARA BAYLOR COLLEGE OF MEDICINE TX $318,513
Hodgkin's Disease 2010 NCI 5R01CA047006-23 Epstein-Barr Virus Nuclear Proteins in B Cell Growth Transformation KIEFF, ELLIOTT BRIGHAM AND WOMEN'S HOSPITAL MA $571,286
Hodgkin's Disease 2010 NCI 5R03CA134159-02 Enhanced Self-Appraisal After Cancer: A Bias in Survivors' Self-Report? RECKLITIS, CHRISTOPHER DANA-FARBER CANCER INSTITUTE MA $85,203
Hodgkin's Disease 2010 NCI 5R01CA085180-10 Epstein-Barr Virus LMP-1 Mediated Oncongenicity KIEFF, ELLIOTT BRIGHAM AND WOMEN'S HOSPITAL MA $714,849
Hodgkin's Disease 2010 NCI 1R01CA140245-01A1 Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction PALOMARES, MELANIE CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CA $709,292
Hodgkin's Disease 2010 NIDCR 5R01DE017336-05 Epigenetic Regulation of Epstein-Barr Virus Latency Programs LIEBERMAN, PAUL WISTAR INSTITUTE PA $321,316
Hodgkin's Disease 2010 NCI 5R01CA127530-03 The role of protein kinase PKK in BAFF signaling and B-cell malignancies ZHAO, JIYONG UNIVERSITY OF ROCHESTER NY $319,550
Hodgkin's Disease 2010 NCI 5R01CA127433-04 Signal transduction inhibitor therapy for Lymphoma WITZIG, THOMAS MAYO CLINIC MN $339,520
Hodgkin's Disease 2010 NIAID 5R43AI079928-02 Novel Inhibitors of Latent Epstein Barr Virus Infection MESSICK, TROY VIRONIKA, LLC PA $76,143
Hodgkin's Disease 2010 NHLBI 1R01HL094603-01A1 Chronic High EBV load and risk of PTLD in Pediatric Heart Transplant Patients METES, DIANA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $369,995
Hodgkin's Disease 2010 NCI 5P01CA015396-35 0020 Hodgkin's Lymphoma Stem Cells AMBINDER, RICHARD JOHNS HOPKINS UNIVERSITY MD $369,477
Hodgkin's Disease 2010 NCI 3R01CA047006-22S1 Epstein-Barr Virus Nuclear Proteins in B Cell Growth Transformation KIEFF, ELLIOTT BRIGHAM AND WOMEN'S HOSPITAL MA $19,977
Hodgkin's Disease 2010 NCI 5P01CA022443-33 0010 Inhibiting The Survival And Proliferation Of EBV-Associated Tumor Cells KENNEY, SHANNON UNIVERSITY OF WISCONSIN MADISON WI $370,720
Hodgkin's Disease 2010 NCI 5P01CA022443-33 0013 Mechanisms of Reactivation of Epstein-Barr Virus from Latency to Lytic Replicatio MERTZ, JANET UNIVERSITY OF WISCONSIN MADISON WI $320,094
Hodgkin's Disease 2010 NCI 5P01CA078902-12 8825 Allogeneic HCT for Hematologic Malignancies: Pharmacologic Manipulations MALONEY, DAVID FRED HUTCHINSON CANCER RESEARCH CENTER WA $185,605
Hodgkin's Disease 2010 NCI 5P50CA097274-09 0002 P2 - Signal Transduction Inhibitor Therapy for Lymphoma WITZIG, THOMAS UNIVERSITY OF IOWA IA $297,339
Hodgkin's Disease 2010 NCI 3R01CA133063-03S1 Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD LONGNECKER, RICHARD NORTHWESTERN UNIVERSITY IL $82,361
Hodgkin's Disease 2010 NCI 5P01CA030206-28 0020 Radioimmunotherapy Based Transplant Regimens for Treatment of B-Cell Lymphoma and FORMAN, STEPHEN CITY OF HOPE NATIONAL MEDICAL CENTER CA $1,136,991
Hodgkin's Disease 2010 RMAP 5P01CA030206-28 0020 Radioimmunotherapy Based Transplant Regimens for Treatment of B-Cell Lymphoma and FORMAN, STEPHEN CITY OF HOPE NATIONAL MEDICAL CENTER CA $11,120
Hodgkin's Disease 2010 NCI 5P01CA092625-10 0009 Molecular Heterogeneity and Rational Thereapeutic Targets in Large B-Cell Lymphom SHIPP, MARGARET DANA-FARBER CANCER INSTITUTE MA $351,131
Hodgkin's Disease 2010 NCI 5P50CA136411-02 5412 Epigenetic-based therapy of Hodgkin lymphoma YOUNES, ANAS UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $69,164
Hodgkin's Disease 2010 NCI 5P50CA126752-04 0001 Immunotherapy for Hodgkin's Disease ROONEY, CLIONA BAYLOR COLLEGE OF MEDICINE TX $285,478
Hodgkin's Disease 2010 NCI 5P50CA126752-04 0003 T Cell Therapy Targeting LMP1 and 2 in EBV+VE Lymphomas GOTTSCHALK, STEPHEN BAYLOR COLLEGE OF MEDICINE TX $296,903
Hodgkin's Disease 2010 NCI 3R01CA133063-03S2 Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD LONGNECKER, RICHARD NORTHWESTERN UNIVERSITY IL $134,365
Hodgkin's Disease 2010 NIAID 1ZIAAI000858-11 Lymphomas And Retroviral Pathogenesis MORSE, HERBERT NIH $876,350
Hodgkin's Disease 2010 NCI 1ZIABC011070-03 Hematopathology Diagnosis JAFFE, ELAINE NIH $288,193
Hodgkin's Disease 2010 NCI 1ZIABC011338-01 Functional Analysis of the REL Transcription Factors in B-Cells LEWIS, BRIAN NIH $417,853
Hodgkin's Disease 2010 NCI 1ZIACP010131-15 Studies of Medical Radiation and Other Therapeutic Agents BERRINGTON, AMY NIH $3,960,538
Hodgkin's Disease 2010 NCI 1ZIACP010214-01 Microbes and Human Malignancies GOEDERT, JAMES NIH $1,990,497
Hodgkin's Disease 2010 NCI 1ZIASC000550-30 Lymphoma Disease Discovery and Defintion JAFFE, ELAINE NIH $1,029,259
Hodgkin's Disease 2010 NCI 1ZIASC004002-41 IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design WALDMANN, THOMAS NIH $1,614,069
Hodgkin's Disease 2010 NCRR 5M01RR000188-46 6547 ADMINISTRATION OF TGF-B RESISTANT LMP2A-SPECIFIC CYTOTOXIC T-LYMPHOCYTES TO P BOLLARD, CATHERINE BAYLOR COLLEGE OF MEDICINE TX $4,197
Hodgkin's Disease 2010 NCRR 5M01RR000188-46 6573 PROCUREMENT OF TISSUE FOR MAKING EPSTEIN-BARR VIRUS (EBV) SPECIFIC CYTOTOXIC T HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE TX $1,145
Hodgkin's Disease 2010 NCRR 5M01RR000188-46 6623 CLINICAL TRIAL: NEOMYCIN RESISTANCE LMP2A SPECIFIC CYTOTOXIC T-LYMPHOCYTES FOR E BOLLARD, CATHERINE BAYLOR COLLEGE OF MEDICINE TX $33,954
Hodgkin's Disease 2010 NCRR 5P51RR000168-49 8712 PATHOGENESIS OF EPSTEIN-BARR VIRUS INFECTION WANG, FREDERICK HARVARD UNIVERSITY (MEDICAL SCHOOL) MA $65,759
Hodgkin's Disease 2010 NCI 2P30CA124435-04 6484 Lymphoma LEVY, RONALD STANFORD UNIVERSITY CA $17,352
Hodgkin's Disease 2010 NCI 5P01CA094237-08 0001 OVERCOMING TUMOR EVASION MECHANISMS IN HODGKIN DISEASE ROONEY, CLIONA BAYLOR COLLEGE OF MEDICINE TX $280,910
Hodgkin's Disease 2010 NCI 5P01CA094237-08 0002 THE ROLE AND MECHANISMS OF CD4+ T CELLS IN ANTITUMOR IMMUNITY WANG, RONGFU BAYLOR COLLEGE OF MEDICINE TX $279,400


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer